Guy Massicotte, PhD - Publications

Chimie-Biologie Université du Québec à Trois-Rivières 
Neuroscience, memory, plasticity

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Pépin É, Jalinier T, Lemieux GL, Massicotte G, Cyr M. Sphingosine-1-Phosphate Receptors Modulators Decrease Signs of Neuroinflammation and Prevent Parkinson's Disease Symptoms in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model. Frontiers in Pharmacology. 11: 77. PMID 32153401 DOI: 10.3389/Fphar.2020.00077  0.414
2017 St-Cyr Giguère F, Attiori Essis S, Chagniel L, Germain M, Cyr M, Massicotte G. The sphingosine-1-phosphate receptor 1 agonist SEW2871 reduces Tau-Ser262 phosphorylation in rat hippocampal slices. Brain Research. PMID 28104351 DOI: 10.1016/J.Brainres.2017.01.014  0.384
2015 Attiori Essis S, Laurier-Laurin ME, Pépin É, Cyr M, Massicotte G. GluN2B-containing NMDA receptors are upregulated in plasma membranes by the sphingosine-1-phosphate analog FTY720P. Brain Research. 1624: 349-58. PMID 26260438 DOI: 10.1016/J.Brainres.2015.07.055  0.53
2014 Laurier-Laurin ME, De Montigny A, Attiori Essis S, Cyr M, Massicotte G. Blockade of lysosomal acid ceramidase induces GluN2B-dependent Tau phosphorylation in rat hippocampal slices. Neural Plasticity. 2014: 196812. PMID 25276436 DOI: 10.1155/2014/196812  0.56
2013 De Montigny A, Elhiri I, Allyson J, Cyr M, Massicotte G. NMDA reduces Tau phosphorylation in rat hippocampal slices by targeting NR2A receptors, GSK3β, and PKC activities. Neural Plasticity. 2013: 261593. PMID 24349798 DOI: 10.1155/2013/261593  0.502
2012 Allyson J, Bi X, Baudry M, Massicotte G. Maintenance of synaptic stability requires calcium-independent phospholipase Aâ‚‚ activity. Neural Plasticity. 2012: 569149. PMID 22685677 DOI: 10.1155/2012/569149  0.616
2012 Dontigny E, Patenaude C, Cyr M, Massicotte G. Sphingomyelinase selectively reduces M1 muscarinic receptors in rat hippocampal membranes. Hippocampus. 22: 1589-96. PMID 22228652 DOI: 10.1002/Hipo.21001  0.477
2010 Allyson J, Dontigny E, Auberson Y, Cyr M, Massicotte G. Blockade of NR2A-containing NMDA receptors induces Tau phosphorylation in rat hippocampal slices. Neural Plasticity. 2010: 340168. PMID 20508838 DOI: 10.1155/2010/340168  0.543
2009 Lebel M, Patenaude C, Allyson J, Massicotte G, Cyr M. Dopamine D1 receptor activation induces tau phosphorylation via cdk5 and GSK3 signaling pathways. Neuropharmacology. 57: 392-402. PMID 19591849 DOI: 10.1016/J.Neuropharm.2009.06.041  0.45
2009 Ménard C, Patenaude C, Gagné AM, Massicotte G. AMPA receptor-mediated cell death is reduced by docosahexaenoic acid but not by eicosapentaenoic acid in area CA1 of hippocampal slice cultures. Journal of Neuroscience Research. 87: 876-86. PMID 18951489 DOI: 10.1002/Jnr.21916  0.506
2008 Quach TT, Massicotte G, Belin MF, Honnorat J, Glasper ER, Devries AC, Jakeman LB, Baudry M, Duchemin AM, Kolattukudy PE. CRMP3 is required for hippocampal CA1 dendritic organization and plasticity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 401-9. PMID 17785607 DOI: 10.1096/Fj.07-9012Com  0.537
2007 Ménard C, Chartier E, Patenaude C, Robinson P, Cyr M, Baudry M, Massicotte G. Calcium-independent phospholipase A(2) influences AMPA-mediated toxicity of hippocampal slices by regulating the GluR1 subunit in synaptic membranes. Hippocampus. 17: 1109-20. PMID 17696174 DOI: 10.1002/Hipo.20343  0.681
2006 Martel MA, Patenaude C, Ménard C, Alaux S, Cummings BS, Massicotte G. A novel role for calcium-independent phospholipase A in alpha-amino-3-hydroxy-5-methylisoxazole-propionate receptor regulation during long-term potentiation. The European Journal of Neuroscience. 23: 505-13. PMID 16420457 DOI: 10.1111/J.1460-9568.2005.04565.X  0.528
2005 Ménard C, Patenaude C, Massicotte G. Phosphorylation of AMPA receptor subunits is differentially regulated by phospholipase A2 inhibitors. Neuroscience Letters. 389: 51-6. PMID 16099093 DOI: 10.1016/J.Neulet.2005.07.012  0.56
2005 Patenaude C, Massicotte G, Lacaille JC. Cell-type specific GABA synaptic transmission and activity-dependent plasticity in rat hippocampal stratum radiatum interneurons. The European Journal of Neuroscience. 22: 179-88. PMID 16029207 DOI: 10.1111/J.1460-9568.2005.04207.X  0.409
2005 Ménard C, Valastro B, Martel MA, Chartier E, Marineau A, Baudry M, Massicotte G. AMPA receptor phosphorylation is selectively regulated by constitutive phospholipase A(2) and 5-lipoxygenase activities. Hippocampus. 15: 370-80. PMID 15630695 DOI: 10.1002/Hipo.20061  0.811
2004 Bélanger A, Lavoie N, Trudeau F, Massicotte G, Gagnon S. Preserved LTP and water maze learning in hyperglycaemic-hyperinsulinemic ZDF rats. Physiology & Behavior. 83: 483-94. PMID 15581671 DOI: 10.1016/J.Physbeh.2004.08.031  0.314
2004 Massicotte G, Baudry M. Brain plasticity and remodeling of AMPA receptor properties by calcium-dependent enzymes. Genetic Engineering. 26: 239-54. PMID 15387300 DOI: 10.1007/978-0-306-48573-2_12  0.673
2004 Gélinas S, Bureau G, Valastro B, Massicotte G, Cicchetti F, Chiasson K, Gagne B, Blanchet J, Martinoli MG. Alpha and beta estradiol protect neuronal but not native PC12 cells from paraquat-induced oxidative stress. Neurotoxicity Research. 6: 141-8. PMID 15325966 DOI: 10.1007/Bf03033216  0.705
2004 St-Gelais F, Ménard C, Congar P, Trudeau LE, Massicotte G. Postsynaptic injection of calcium-independent phospholipase A2 inhibitors selectively increases AMPA receptor-mediated synaptic transmission. Hippocampus. 14: 319-25. PMID 15132431 DOI: 10.1002/Hipo.10176  0.594
2004 Ménard C, Valastro B, Martel MA, Martinoli MG, Massicotte G. Strain-related variations of AMPA receptor modulation by calcium-dependent mechanisms in the hippocampus: contribution of lipoxygenase metabolites of arachidonic acid. Brain Research. 1010: 134-43. PMID 15126126 DOI: 10.1016/J.Brainres.2004.03.012  0.786
2004 Trudeau F, Gagnon S, Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. European Journal of Pharmacology. 490: 177-86. PMID 15094084 DOI: 10.1016/J.Ejphar.2004.02.055  0.429
2002 Valastro B, Cossette J, Lavoie N, Gagnon S, Trudeau F, Massicotte G. Up-regulation of glutamate receptors is associated with LTP defects in the early stages of diabetes mellitus. Diabetologia. 45: 642-50. PMID 12107744 DOI: 10.1007/s00125-002-0818-5  0.757
2001 Valastro B, Girard M, Gagné J, Martin F, Parent AT, Baudry M, Massicotte G. Inositol hexakisphosphate-mediated regulation of glutamate receptors in rat brain sections. Hippocampus. 11: 673-82. PMID 11811661 DOI: 10.1002/Hipo.1082  0.816
2001 Valastro B, Ghribi O, Poirier J, Krzywkowski P, Massicotte G. AMPA receptor regulation and LTP in the hippocampus of young and aged apolipoprotein E-deficient mice. Neurobiology of Aging. 22: 9-15. PMID 11164271 DOI: 10.1016/S0197-4580(00)00177-9  0.772
2000 Lapierre L, Valastro B, Miceli D, Massicotte G. AMPA receptor modulation in previously frozen mouse brain sections: opposite effects of calcium in the cortex and hippocampus. Hippocampus. 10: 645-53. PMID 11153710 DOI: 10.1002/1098-1063(2000)10:6<645::Aid-Hipo1002>3.0.Co;2-U  0.808
2000 Massicotte G. Modification of glutamate receptors by phospholipase A2: its role in adaptive neural plasticity. Cellular and Molecular Life Sciences : Cmls. 57: 1542-50. PMID 11092449  0.496
2000 Furling D, Ghribi O, Lahsaini A, Mirault ME, Massicotte G. Impairment of synaptic transmission by transient hypoxia in hippocampal slices: improved recovery in glutathione peroxidase transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 97: 4351-6. PMID 10759548 DOI: 10.1073/Pnas.060574597  0.428
1999 Krzywkowski P, Ghribi O, Gagné J, Chabot C, Kar S, Rochford J, Massicotte G, Poirier J. Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice. Neuroscience. 92: 1273-86. PMID 10426483 DOI: 10.1016/S0306-4522(99)00061-5  0.332
1999 Ghribi O, Lapierre L, Girard M, Ohayon M, Nalbantoglu J, Massicotte G. Hypoxia-induced loss of synaptic transmission is exacerbated in hippocampal slices of transgenic mice expressing C-terminal fragments of Alzheimer amyloid precursor protein. Hippocampus. 9: 201-5. PMID 10401636 DOI: 10.1002/(Sici)1098-1063(1999)9:3<201::Aid-Hipo1>3.0.Co;2-P  0.409
1998 Gagné J, Gélinas S, Martinoli MG, Foster TC, Ohayon M, Thompson RF, Baudry M, Massicotte G. AMPA receptor properties in adult rat hippocampus following environmental enrichment. Brain Research. 799: 16-25. PMID 9666061 DOI: 10.1016/S0006-8993(98)00451-X  0.678
1998 Chabot C, Gagné J, Giguère C, Bernard J, Baudry M, Massicotte G. Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus. Hippocampus. 8: 299-309. PMID 9662143 DOI: 10.1002/(Sici)1098-1063(1998)8:3<299::Aid-Hipo11>3.0.Co;2-W  0.727
1997 Chabot C, Massicotte G, Milot M, Trudeau F, Gagné J. Impaired modulation of AMPA receptors by calcium-dependent processes in streptozotocin-induced diabetic rats. Brain Research. 768: 249-56. PMID 9369322 DOI: 10.1016/S0006-8993(97)00648-3  0.588
1997 Nalbantoglu J, Tirado-Santiago G, Lahsaïni A, Poirier J, Goncalves O, Verge G, Momoli F, Welner SA, Massicotte G, Julien JP, Shapiro ML. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature. 387: 500-5. PMID 9168112 DOI: 10.1038/387500A0  0.303
1997 Gagné J, Milot M, Gélinas S, Lahsaïni A, Trudeau F, Martinoli MG, Massicotte G. Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats. Diabetes. 46: 841-6. PMID 9133553  0.502
1996 Gagné J, Giguère C, Tocco G, Ohayon M, Thompson RF, Baudry M, Massicotte G. Effect of phosphatidylserine on the binding properties of glutamate receptors in brain sections from adult and neonatal rats. Brain Research. 740: 337-45. PMID 8973832 DOI: 10.1016/S0006-8993(96)00897-9  0.708
1996 Foster TC, Gagne J, Massicotte G. Mechanism of altered synaptic strength due to experience: relation to long-term potentiation. Brain Research. 736: 243-50. PMID 8930330 DOI: 10.1016/0006-8993(96)00707-X  0.449
1996 Normandin M, Gagné J, Bernard J, Elie R, Miceli D, Baudry M, Massicotte G. Involvement of the 12-lipoxygenase pathway of arachidonic acid metabolism in homosynaptic long-term depression of the rat hippocampus. Brain Research. 730: 40-6. PMID 8883886 DOI: 10.1016/0006-8993(96)00428-3  0.601
1996 Chabot C, Bernard J, Normandin M, Ohayon M, Baudry M, Massicotte G. Developmental changes in depolarization-mediated AMPA receptor modifications and potassium-induced long-term potentiation. Brain Research. Developmental Brain Research. 93: 70-5. PMID 8804693 DOI: 10.1016/0165-3806(96)00021-1  0.687
1995 Bernard J, Chabot C, Gagné J, Baudry M, Massicotte G. Melittin increases AMPA receptor affinity in rat brain synaptoneurosomes. Brain Research. 671: 195-200. PMID 7743208 DOI: 10.1016/0006-8993(94)01313-7  0.729
1995 Standley S, Tocco G, Tourigny MF, Massicotte G, Thompson RF, Baudry M. Developmental changes in alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor properties and expression in the rat hippocampal formation. Neuroscience. 67: 881-92. PMID 7545799 DOI: 10.1016/0306-4522(95)00075-T  0.62
1994 Bernard J, Ohayon M, Massicotte G. Modulation of the AMPA receptor by phospholipase A2: effect of the antidepressant trimipramine. Psychiatry Research. 51: 107-14. PMID 7912839 DOI: 10.1016/0165-1781(94)90030-2  0.609
1994 Bernard J, Lahsaini A, Massicotte G. Potassium-induced long-term potentiation in area CA1 of the hippocampus involves phospholipase activation. Hippocampus. 4: 447-53. PMID 7874236 DOI: 10.1002/Hipo.450040407  0.509
1993 Massicotte G, Bernard J, Ohayon M. Chronic effects of trimipramine, an antidepressant, on hippocampal synaptic plasticity. Behavioral and Neural Biology. 59: 100-6. PMID 8476377 DOI: 10.1016/0163-1047(93)90808-U  0.516
1993 Hall RA, Massicotte G, Kessler M, Baudry M, Lynch G. Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states. Molecular Pharmacology. 43: 459-64. PMID 7680752  0.609
1993 Bernard J, Lahsaïni A, Baudry M, Massicotte G. The phospholipase A2 inhibitor bromophenacyl bromide prevents the depolarization-induced increase in [3H]AMPA binding in rat brain synaptoneurosomes. Brain Research. 628: 340-4. PMID 7508812 DOI: 10.1016/0006-8993(93)90977-U  0.664
1992 Tocco G, Massicotte G, Standley S, Thompson RF, Baudry M. Effect of Temperature and Calcium on the Binding Properties of the AMPA Receptor in Frozen Rat Brain Sections. The European Journal of Neuroscience. 4: 1093-1103. PMID 12106415 DOI: 10.1111/J.1460-9568.1992.Tb00136.X  0.701
1992 Najm I, el-Skaf G, Massicotte G, Vanderklish P, Lynch G, Baudry M. Changes in polyamine levels and spectrin degradation following kainate-induced seizure activity: effect of difluoromethylornithine. Experimental Neurology. 116: 345-54. PMID 1587335 DOI: 10.1016/0014-4886(92)90013-G  0.657
1992 Tocco G, Massicotte G, Standley S, Thompson RF, Baudry M. Phospholipase A2-induced changes in AMPA receptor: an autoradiographic study. Neuroreport. 3: 515-8. PMID 1382660 DOI: 10.1097/00001756-199206000-00015  0.693
1992 Bernard J, Massicotte G, Baudry M. Potassium-induced depolarization of rat telencephalic synaptoneurosomes increases [3H]amino-3-hydroxy-5-methylisoxazole-4-propionate receptor binding. Journal of Neurochemistry. 58: 387-9. PMID 1370080 DOI: 10.1111/j.1471-4159.1992.tb09323.x  0.653
1992 Massicotte G, Bernard J, Baudry M. Postnatal changes in AMPA receptor regulation by phospholipase A2 treatment of synaptic membranes: temporally differential effects on agonist and antagonist binding. Brain Research. Developmental Brain Research. 66: 203-8. PMID 1351426 DOI: 10.1016/0165-3806(92)90081-7  0.592
1991 Massicotte G, Baudry M. Triggers and substrates of hippocampal synaptic plasticity. Neuroscience and Biobehavioral Reviews. 15: 415-23. PMID 1956609 DOI: 10.1016/S0149-7634(05)80034-X  0.5
1991 Massicotte G, Vanderklish P, Lynch G, Baudry M. Modulation of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/quisqualate receptors by phospholipase A2: a necessary step in long-term potentiation? Proceedings of the National Academy of Sciences of the United States of America. 88: 1893-7. PMID 1848014 DOI: 10.1073/Pnas.88.5.1893  0.762
1991 Baudry M, Massicotte G, Hauge S. Opposite effects of phospholipase A2 on [3H]AMPA binding in adult and neonatal membranes. Brain Research. Developmental Brain Research. 61: 265-7. PMID 1661214 DOI: 10.1016/0165-3806(91)90140-E  0.628
1991 Baudry M, Massicotte G, Hauge S. Phosphatidylserine increases the affinity of the AMPA/quisqualate receptor in rat brain membranes. Behavioral and Neural Biology. 55: 137-40. PMID 1647760 DOI: 10.1016/0163-1047(91)80134-Z  0.618
1990 Massicotte G, Coderre L, Chiasson JL, Thibault G, Schiffrin EL, St-Louis J. Regulation of ANG II and AVP receptors in isolated hepatocytes of pregnant rats. The American Journal of Physiology. 258: E597-605. PMID 2333959 DOI: 10.1152/Ajpendo.1990.258.4.E597  0.376
1990 Massicotte G, Baudry M. Modulation of DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/quisqualate receptors by phospholipase A2 treatment. Neuroscience Letters. 118: 245-8. PMID 2177177 DOI: 10.1016/0304-3940(90)90638-P  0.709
1990 Massicotte G, Kessler M, Lynch G, Baudry M. N-Methyl-D-aspartate and quisqualate/DL-alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid receptors: differential regulation by phospholipase C treatment. Molecular Pharmacology. 37: 278-85. PMID 2154675  0.658
1990 Massicotte G, Oliver MW, Lynch G, Baudry M. Effect of bromophenacyl bromide, a phospholipase A2 inhibitor, on the induction and maintenance of LTP in hippocampal slices. Brain Research. 537: 49-53. PMID 2150777 DOI: 10.1016/0006-8993(90)90338-C  0.632
Show low-probability matches.